Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.ady5599
Affiliations:
7
Authors:
20
Go to article
Institutions Authors Share
Garvan Institute of Medical Research, Australia
11.500000
11.500000
 0.58
University of New South Wales (UNSW Sydney), Australia
3.833333
 0.19
Lowy Cancer Research Centre, Australia
2.333333
 0.12
University College Dublin (UCD), Ireland
2.000000
 0.10
Sydney Children's Hospital, Randwick, Australia
0.333333
 0.02
Interested in Oncology and Carcinogenesis?